Acasti Pharma Appoints Prashant Kohli as CEO with Incentives

Acasti Pharma (ACST) just unveiled an announcement.

Acasti Pharma Inc. has signed an employment agreement with Prashant Kohli as its CEO, offering a $500,000 annual salary and up to a 50% performance-based bonus. The contract includes potential stock options under the company’s plan, subject to board approval and terms. Kohli’s role comes with confidentiality and non-compete clauses and, if terminated without cause, he is entitled to a year’s salary. The agreement ensures participation in standard company benefits and contains provisions for proprietary property rights and confidentiality.

For an in-depth examination of ACST stock, go to TipRanks’ Stock Analysis page.